For condition: Psoriasis
Teen Plaque Psoriasis Research Trial (78 Weeks)
Study Summary
Who Can Participate?
Adolescents 12 to <18 years of age with plaque psoriasis, may be eligible.
Inclusion Criteria:
-
-
- Diagnosis of stable plaque psoriasis for 6 months or more
- Moderate to severe psoriasis, including a Body Surface Area (BSA) ≥ 10% involvement
- Permitted to enroll with a medical history or symptoms suggestive of Juvenile Psoriatic Arthritis (JPsA) as long as treatment of JPsA does not require prohibited medications
- Have all immunizations up-to-date
-
Participant Info:
-
-
- No cost to participate or receive study medication
- Regular visits with study doctors who are familiar with treating plaque psoriasis
- Will receive investigational oral medication (active study drug) or placebo, during the main study
- Reimbursement for study-related expenses may be provided
-
How Long Will The Study Last?
-
-
- In the main study, individuals will be asked to visit the study centre about 14 times over a period of about 78 weeks. The main study will be followed by an optional open-label long-term extension (LTE) period with a duration of up to 5 years.
-
For more information about this trial, please visit ClinicalTrials.gov
